Abstract
Summary. In this study, we compared the effects of pimobenda (PIM), a putative Ca2+-sensitizer and phosphodiesterase (PDE) inhibitor, on the L-type Ca2+ current (ICa) of guinea-pig ventricular myocytes and contractile tension of ventricular papillary muscles with those of a nonselective PDE inhibitor, isobutylmethylxanthine (IBMX), and selective PDE-III inhibitors, that is, milrinone (MIL) and cilostazol (CIL). The efficacy (maximum attainable effect) of these drugs for increasing ICa or developed tension (DT) ranged in the order of IBMX ≫ MIL > PIM > CIL. This finding suggests that the positive inotropic effect of each drug is roughly proportional to its increasing effect on ICa. The additional effect of PIM (a Ca2+-sensitizing effect) was not identified in “intact” preparations, and the potentiating effects of PIM on the DT and ICa were virtually the same as those observed for MIL. To isolate the Ca2+-sensitizing effect of PIM on the DT, we studied the effects of PIM in the presence of H89, an isoquinoline derivative possessing a selective inhibitory effect on cAMP-dependent protein kinase. In the absence of H89, 50 µM PIM increased the DT by 68 ± 11% (mean ± SE, n = 6). However, in the presence of 20 µM H89, which completely blocked the PIM-induced increase in ICa, PIM (50 µM) significantly increased the DT by 19 ± 6% (n = 6), thereby indicating the presence of a positive inotropic effect attributable to a mechanism other than increased intracellular cAMP, that is, a Ca2+-sensitizing effect. The latter notion was supported by the finding that in the presence of H89 (20 µM), the PIM-induced augmentation of DT was accompanied by a prolongation of the time to 50% relaxation of contractile tension. In contrast, MIL (50 µM) and forskolin, a direct activator of adenylate cyclase (1–10 nM), did not increase DT in the presence of 20 µM H89. These results suggest that the fraction of positive inotropic effect of PIM attributable to its Ca2+-sensitizing effect is masked by its potent PDE-III inhibitory effect in “intact” ventricular preparations.
Similar content being viewed by others
References
Fujino K, Sperelakis N, Solaro RJ. Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: Comparison with milrinone. Circ Res 1988;63:911–922.
Lee JA, Ruegg JC, Allen DG. Effects of pimobendan, a novel inotropic agent, on intracellular calcium and tension in isolated ferret ventricular muscle. Clin Sci 1989;76:609–618.
Hagemeijer F. Calcium sensitization with pimobendan: Pharmacology, haemodynamic improvement, and sudden death in patients with chronic congestive heart failure. Eur Heart J 1993;14:551–566.
Cruickshank JM. Phosphodiesterase III inhibitors: Longterm risks and short-term benefits. Cardiovasc Drugs Ther 1993;7:655–660.
Kimura Y, Tani T, Kanbe T, Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung 1985;35(II):1144–1149.
Chijiwa T, Mashima A, Hagiwara M, et al. Inhibition of forskolin-induced phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamyl amino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 1990;265:5267–5272.
Muramatsu H, Kiyosue T, Arita M, Ishikawa T, Hidaka H. Modification of cardiac sodium current by intracellular application of cAMP. Pflügers Arch 1994;426:146–154.
Matsui K, Kiyosue T, Arita M. Effects of PDE-inhibitors on L-type Ca2+ current and developed tension in guinea pig ventricular myocytes and muscles. J Mol Cell Cardiol 1996;28:A311.
Taniguchi M, Kokubun S, Noma A, Irisawa H. Spontaneously active cells isolated from the sino-atrial and atrio-ventricular nodes of rabbit heart. Jpn J Physiol 1981;31:547–558.
Wang DW, Kiyosue T, Sato T, Arita M. Comparison of the effects of class I anti-arrhythmic drugs, cibenzoline, mexiletine and flecainide, on the delayed rectifier K+ current of guinea-pig ventricular myocytes. J Mol Cell Cardiol 1996;28:893–903.
Marty A, Neher E. Tight-seal whole-cell recording. In: Sakmann B, Neher E, eds. Single-Channel Recordings. New York: Plenum Press, 1983:107–122.
Tallarida RJ, Jakob LS (Eds). The Dose-Response Relation in Pharmacology. New York: Springer-Verlag, 1979.
Yuan W, Bers DM. Protein kinase inhibitor H-89 reverses forskolin stimulation of cardiac L-type calcium current. Am J Physiol 1995;268:C651–C659.
Arita M, Muramatsu H, Ono K, Kiyosue T. β-adrenergic regulation of cardiac Na+ channel. In: Morad M, Ebashi S, Trautwein W, Kurachi Y, eds. Molecular Physiology and Pharmacology of Cardiac Ion Channels and Transporters. Dordrecht: Kluwer Academic, 1996:53–62.
Seamon KB, Daly JW. Forskolin: A unique diterpene activator of cyclic AMP-generating systems. J Cycl Nucl Res 1981;7:201–224.
Tatsukawa Y, Arita M, Kiyosue T, Mikuriya Y, Nasu M. A comparative study of effects of isoproterenol and dihydroouabain on calcium transients and contraction in cultured rat ventricular cells. J Mol Cell Cardiol 1993;25:707–720
Tada M, Katz AM. Phosphorylation of the sarcoplasmic reticulum and sarcolemma. Annu Rev Physiol 1982;44:401–423.
Bethke T, Meyer W, Schmitz W, et al. Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea pig hearts. Br J Pharmacol 1992;107:127–133.
Persons WJ, Ramkumar V, Stiles GL. Isobutylmethylxanthine stimulates adenylate cyclase by blocking the inhibitory regulatory protein, Gi. Mol Pharmacol 1988;34:37–41.
Atarashi H, Endoh Y, Saitoh H, Kishida H, Hayakawa H. Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias. J Cardiovasc Pharmacol 1998;31:534–539.
Scheld HH, Fritsche R, Schlepper M, van Meel JCA. Pimobendan increases calcium sensitivity of skinned human papillary muscle fibers. J Clin Pharmacol 1989;29:360–365.
DiFrancesco D, Tortota P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 1991;351:145–147
Kelso EJ, McDermott BJ, Silke B. Differential effects of phosphodiesterase inhibitors on accumulation of cyclic AMP in isolated ventricular cardiomyocytes. Biochem Pharmacol 1995;49:441–452.
Kass RS, Lederer WJ, Tsien RW, Weingart E. Role of calcium ions in transient inward currents and aftercontractions induced by strophanthidin in cardiac Purkinje fibres. J Physiol 1978;281:187–208
Bohm M, Diet F, Feiler G, et al. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to β-adrenoceptor downregulation. J Cardiovasc Pharmacol 1988;12:726–732
Feldman MD, Copelas L, Gwathmey JK, et al. Deficient production of cyclic AMP: Pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 1987;75:331–339.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsui, K., Kiyosue, T., Wang, JC. et al. Effects of Pimobendan on the L-Type Ca2+ Current and Developed Tension in Guinea-Pig Ventricular Myocytes and Papillary Muscle: Comparison with IBMX, Milrinone, and Cilostazol. Cardiovasc Drugs Ther 13, 105–113 (1999). https://doi.org/10.1023/A:1007779908346
Issue Date:
DOI: https://doi.org/10.1023/A:1007779908346